Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List

Digestive Diseases and Sciences

Volumn 61, Issue 1, 2016, Pages 309-316

  Urrunaga, Nathalie H ^a   Magder, Laurence S ^a   Weir, Matthew R ^a   Rockey, Don C ^b   Mindikoglu, Ayse L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Acute liver failure; CKD EPI; Liver transplantation; OPTN; Renal dysfunction

Indexed keywords

ADULT; CHI SQUARE DISTRIBUTION; FACTUAL DATABASE; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TRANSPLANTATION; UNITED STATES;

ADULT; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 84952987106     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3870-y     Document Type: Article

References (49)

1. Lee WM, Stravitz RT, Larson AMCP. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2011;55:965–967.
2. Polson J, Lee WM. Disease AAftSoL. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–1197.
3. Czaja AJ, Freese DK. Disease AAftSoL. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497.
4. Lee WC, Wu MJ, Cheng CH, et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis. 2001;38:1074–1081.
5. Peters DJ, Greene WH, Ruggiero F, et al. Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci. 2000;45:2399–2404.
6. Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557–1562.
7. Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.
8. O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.
9. Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology. 2013;57:753–762.
10. Mindikoglu AL, Regev A, Seliger SL, et al. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010;16:1147–1157.
11. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
12. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147.
13. SAS Activity-Based Management 6.3: User’s Guide. Cary, N.C.: SAS Institute, Inc.; 2007.
14. Minitab 16 Statistical Software (2010). Computer Software. State College, PA: Minitab, Inc. (www.minitab.com).
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958;53:457–481.
16. Cox DR. Regression models and life-table. J R Stat Soc B. 1972;34:187–220.
17. Wilkinson SP, Moodie H, Arroyo VA, et al. Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol. 1977;30:141–143.
18. Wilkinson SP, Blendis LM, Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure. Br Med J. 1974;1:186–189.
19. Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–359.
20. Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.
21. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut. 1981;22:585–591.
22. Garcin JM, Bronstein JA, Cremades S, et al. Acute liver failure is frequent during heat stroke. World J Gastroenterol. 2008;14:158–159.
23. Jin Q, Chen E, Jiang J, et al. Acute hepatic failure as a leading manifestation in exertional heat stroke. Case Rep Crit Care. 2012;2012:295867.
24. Yeo TP. Heat stroke: a comprehensive review. AACN Clin Issues. 2004;15:280–293.
25. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000–1006.
26. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389–395.
27. Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419.
28. Rosenfeld J, Gura V, Boner G, et al. Interstitial nephritis with acute renal failure after erythromycin. Br Med J (Clin Res Ed). 1983;286:938–939.
29. Soni N, Harrington JW, Weiss R, et al. Recurrent acute interstitial nephritis induced by azithromycin. Pediatr Infect Dis J. 2004;23:965–966.
30. Tintillier M, Kirch L, Almpanis C, et al. Telithromycin-induced acute interstitial nephritis: a first case report. Am J Kidney Dis. 2004;44:e25–e27.
31. Mansoor GA, Panner BJ, Ornt DB. Azithromycin-induced acute interstitial nephritis. Ann Intern Med. 1993;119:636–637.
32. Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009;15:719–729.
33. Polman AJ, van der Werf TS, Tiebosch AT, et al. Early-onset phenytoin toxicity mimicking a renopulmonary syndrome. Eur Respir J. 1998;11:501–503.
34. Hyman LR, Ballow M, Knieser MR. Diphenylhydantoin interstitial nephritis. Roles of cellular and humoral immunologic injury. J Pediatr. 1978;92:915–920.
35. Parry RG, Gordon P, Mason JC, et al. Phenytoin-associated vasculitis and ANCA positivity: a case report. Nephrol Dial Transpl. 1996;11:357–359.
36. Michael JR, Mitch WE. Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA. 1976;236:2773–2775.
37. Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol. 1995;6:48–53.
38. Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.
39. O’Riordan A, Brummell Z, Sizer E, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant. 2011;26:3501–3508.
40. Lines SW, Wood A, Bellamy MC, et al. The outcomes of critically ill patients with combined severe acute liver and kidney injury secondary to paracetamol toxicity requiring renal replacement therapy. Ren Fail. 2011;33:785–788.
41. Fan PC, Chen YC, Tian YC, et al. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail. 2009;31:756–764.
42. Kim HW, Yu MH, Lee JH, et al. Experiences with acute kidney injury complicating non-fulminant hepatitis A. Nephrology (Carlton). 2008;13:451–458.
43. Pal RB, Saha P, Das I, et al. Fulminant hepatitis and glomerulonephritis—a rare presentation of hepatitis A virus infection. Acta Paediatr. 2011;100:e132–e134.
44. McCann UG 2nd, Rabito F, Shah M, et al. Acute renal failure complicating nonfulminant hepatitis A. West J Med. 1996;165:308–310.
45. Jung YJ, Kim W, Jeong JB, et al. Clinical features of acute renal failure associated with hepatitis A virus infection. J Viral Hepat. 2010;17:611–617.
46. Watanabe S, Nomoto H, Matsuda M, et al. A case of acute renal failure associated with type A acute hepatitis responds dramatically to plasmapheresis. Tokai J Exp Clin Med. 1986;11:1–4.
47. Zikos D, Grewal KS, Craig K, et al. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am J Gastroenterol. 1995;90:295–298.
48. Evans JT, Shepard MM, Oates JC, et al. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol. 2008;42:862–863.
49. Section 2: AKI definition. Kidney Int Suppl. 2012;2:19–36.